Lilly to launch Mounjaro pen in India to compete with Novo's Wegovy

Eli Lilly said on Thursday India's drug regulator had approved the launch of pre-filled injector pens of its blockbuster weight-loss drug, Mounjaro, giving it more options to compete with Novo Nordisk's recently launched Wegovy.

Lilly started selling Mounjaro in India in late March for diabetes and obesity, and it was so far available only in vials and in 2.5 mg and 5 mg doses.

The competition in the world's most populous country started heating up after Denmark's Novo Nordisk launched Wegovy in India on Tuesday in multiple dose strengths and an "easy-to-use" pen injector format.


Mounjaro KwikPen, for once-weekly use, has been approved by the Central Drugs Standard Control Organization for six dose strengths of 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg, the company said in a statement.